Back
ProQR Therapeutics NV Vs. Pharming Group Industry Stock Comparison
Sell
27
PRQR
ProQR Therapeutics NV
Last Price:
1.74
Seasonality Move:
-2.94%
Buy
53
PHAR
Pharming Group
Last Price:
7.54
Seasonality Move:
-7.8%
Sell
27
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.79. The Score for PRQR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Pharming Group (PHAR)
is a Buy
Is Pharming Group a Buy, Sell or Hold?
- The current Pharming Group [PHAR] share price is $8.04. The Score for PHAR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PHAR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight buying pressure.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $8.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 34.88 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.83 - 2.09) | Sell |
| Bollinger Bands (100): | (1.74 - 2.02) | Sell |
PHAR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 56.59 | Buy |
| Chaikin Money Flow: | 4474 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.32 - 7.98) | Buy |
| Bollinger Bands (100): | (7.58 - 9.18) | Sell |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.83 | Sell |
| 20-day SMA: | 1.92 | Sell |
| 50-day SMA: | 1.92 | Sell |
| 200-day SMA: | 2 | Sell |
| 8-day EMA: | 1.83 | Sell |
| 20-day EMA: | 1.89 | Sell |
| 50-day EMA: | 1.91 | Sell |
| 200-day EMA: | 1.91 | Sell |
PHAR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.61 | Buy |
| 20-day SMA: | 7.59 | Buy |
| 50-day SMA: | 7.89 | Buy |
| 200-day SMA: | 9.93 | Sell |
| 8-day EMA: | 7.73 | Buy |
| 20-day EMA: | 7.65 | Buy |
| 50-day EMA: | 7.89 | Buy |
| 200-day EMA: | 9.41 | Sell |
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
Pharming Group Earnings Growth & PHAR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
ProQR Therapeutics NV Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pharming Group Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||